Removal of colloids: Evidence- or emotional-based medicine?

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 6, 2013, Pages 809-

  Schramko, A A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

CLINICAL EFFECTIVENESS; COLLOID; DISEASE SEVERITY; EMOTION; EVIDENCE BASED MEDICINE; HEMODYNAMIC MONITORING; HUMAN; HYPERVOLEMIA; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LETTER; PATIENT ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBSTITUTION THERAPY; SURGICAL MORTALITY; SURGICAL PATIENT;

CLINICAL TRIALS AS TOPIC; CRITICAL CARE; HUMANS;

EID: 84878840577     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12122     Document Type: Letter

References (10)

1. Flaatten H, Haney M, Wernerman J,. The Scandinavian critical care trials group: producing important new findings in challenging times. Acta Anaesthesiol Scand 2013; 57: 138-140.
2. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H,. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012; 16: R94.
3. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, 6S Trial Group, Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134.
4. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SAR,. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911.
5. Chappell D, Jacob M,. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367: 1266.
6. Guidet B,. Hydroxyethyl starch or saline in intensive care. N Engl J Med 2013; 368: 774-775.
7. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F, Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003; 238: 641-648.
8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
9. Jacob M, Chappell D, Hofmann-Kiefer K, Helfen T, Schuelke A, Jacob B, Burques A, Conzen P, Rehm M,. The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans. Crit Care 2012; 16: R86.
10. Van Der Linden P, James M, Mythen M, Weiskopf RB,. Safety of modern starches used during surgery. Anesth Analg 2013; 116: 35-48.